… attributed to the increased risk of pneumonia [4]. Inhaled corticosteroid (ICS) administration
is … comorbidities consistently demonstrated an increased risk of pneumonia with ICS use [7]. …

… for the comparator) with 62 cases of pneumonia reported as either an adverse, or serious
adverse event for budesonide, and 82 for the comparator. In the primary data set the rate of …

… inhaled corticosteroids is associated with increases in the risk of infection, especially
pneumonia… and sepsis excluding subjects hospitalized for pneumonia or COPD in the past year …

… of pneumonia adverse events, pneumonia serious adverse events … When analysed at a class
level, inhaled corticosteroid … pneumonia but not to an increased risk of all-cause mortality or …

… Pneumonia is one of the most serious side effects of ICS. The TORCH study reported an
increased risk of pneumonia … pneumonia that revealed a dose-dependent increase in the risk of …

… Pneumonia and pneumonia related mortality in patients with COPD treated with fixed
combinations of inhaled corticosteroids and long acting b2 agonist: observational matched cohort …

… of inhaled corticosteroids and systemic corticosteroids with the risk of pneumonia and the …
than 3,000 COPD patients, reported a higher incidence of serious pneumonia in patients …

… We do not know whether inhaled corticosteroids increase or decrease serious adverse …
In Yu 2021, standard care was specified as antipyretics and antibiotics if bacterial pneumonia …

… in an increase of 17% in the risk of serious pneumonia and was not dose-related. Ernst et
al. confirmed these results, showing a 70% increase in the risk of serious pneumonia in …

… Inhaled corticosteroids (ICS) are associated with an increased risk of clinical pneumonia …
patients and when given in high dose, carry serious adverse effects. Opposite we did find that …